All Press Releases for June 20, 2012

Word of Acceleration of New Jersey Fosamax Femur Fracture Trial Schedule Released by Court

The Rottenstein Law Group has learned that the judge presiding over Fosamax femur fracture cases in the state of New Jersey has chosen to accelerate the trial schedule.



    NEW YORK, NY, June 20, 2012 /24-7PressRelease/ -- The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the osteoporosis drug Fosamax, has learned that the first New Jersey State court trials of cases involving femur fractures alleged to be caused by the drug will precede further trials of cases involving other alleged harms.

By letter dated June 4, 2012, Superior Court of New Jersey Judge Carol E. Higbee informed counsel for parties to the consolidated Fosamax litigation before her (Case No. 282) that rather than try another osteonecrosis of the jaw (ONJ) case next, she will "move to the trial of bellwether cases involving femur fractures." Judge Higbee had intended to assign a second ONJ case for trial to a judge who is now going to be transferred to a different division of the court; no other judge is available to try the case that was going to come up next. Instead, that case will be "placed on hold," and "in the interest of advancing the entire Fosamax litigation," Judge Higbee will be conferring with counsel to finalize selection of the first femur fracture cases to be tried.

Despite being the most popular osteoporosis treatment on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition that causes the jawbone to literally die because of a lack of blood supply. More recently, there has been a link between Fosamax and low-impact femur fractures experienced from standing height or less. Evidence is mounting that Fosamax and other bisphosphonate drugs prescribed to treat osteoporosis cause a dramatic increase in the risk of this kind of rare fracture to the thigh bone.

The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center at www.fosamaxfemurfracturelawsuit.com for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.

About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site at www.rotlaw.com, or call (888) 9-ROT-LAW.

# # #

Contact Information

Nava Brahe
The Rottenstein Law Group
Hewlett, New York
USA
Voice: 212 933-9500
E-Mail: Email Us Here
Website: Visit Our Website